Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Annie M Wu, Kristen M Pitts, Roberto Pineda, Sherleen H Chen, Mengyu Wang, Grace Johnson, Lucy Q Shen & Milica A Margeta. (2023) Steroid Response Following Dropless Cataract Surgery Using Subconjunctival Triamcinolone. Clinical Ophthalmology 17, pages 2803-2814.
Read now
Read now
Carlo Alberto Cutolo, Stefano Barabino, Chiara Bonzano & Carlo Enrico Traverso. (2019) The Use of Topical Corticosteroids for Treatment of Dry Eye Syndrome. Ocular Immunology and Inflammation 27:2, pages 266-275.
Read now
Read now
Articles from other publishers (27)
D. Yu. Maychuk & A. A. Tarkhanova. (2021) Advantages of “Soft Steroids” in the Treatment of Inflammatory Eye Diseases. Оverview. Ophthalmology in Russia 18:4, pages 778-783.
Crossref
Crossref
Karine D. Bojikian, Priscilla Nobrega, Ashley Roldan, Samantha L. Forrest, Mai Tsukikawa & Philip P. Chen. (2021) Incidence of and Risk Factors for Steroid Response After Cataract Surgery in Patients With and Without Glaucoma. Journal of Glaucoma 30:4, pages e159-e163.
Crossref
Crossref
Sara I. Van Acker, Michel Haagdorens, Ella Roelant, Jos Rozema, Tine Possemiers, Veerle Van Gerwen, Marie-José Tassignon, Veva De Groot, Sorcha Ní Dhubhghaill, Carina Koppen & Nadia Zakaria. (2019) Pterygium Pathology: A Prospective Case-Control Study on Tear Film Cytokine Levels. Mediators of Inflammation 2019, pages 1-11.
Crossref
Crossref
Jinsoo KimDong Chul ChoiSeokhyun BaeDong Gyu ChoiJoo Yeon Lee. (2018) A Randomized Clinical Trial of Topical Diclofenac, Fluorometholone, and Dexamethasone for Control of Inflammation After Strabismus Surgery. Journal of Ocular Pharmacology and Therapeutics 34:7, pages 550-554.
Crossref
Crossref
Marius A. Tijunelis, Erica Person, Leslie M. Niziol, David C. Musch, Paul Ernest, Madeline McBain & Shahzad I. Mian. (2017) Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension. Journal of Cataract and Refractive Surgery 43:2, pages 223-227.
Crossref
Crossref
Hee Kyung Yang, Sang Beom Han & Jeong-Min Hwang. (2014) Diclofenac versus fluorometholone after strabismus surgery in children. British Journal of Ophthalmology 98:6, pages 734-738.
Crossref
Crossref
Hugh R Taylor. (2014) Lessons I have learnt about the cornea. Clinical & Experimental Ophthalmology 42:3, pages 296-298.
Crossref
Crossref
Uwe Pleyer, Paul G. Ursell & Paolo Rama. (2013) Intraocular Pressure Effects of Common Topical Steroids for Post-Cataract Inflammation: Are They All the Same?. Ophthalmology and Therapy 2:2, pages 55-72.
Crossref
Crossref
Rajesh K. Rajpal, Lawrence Roel, Raphaele Siou-Mermet & Tara Erb. (2013) Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery. Journal of Cataract and Refractive Surgery 39:2, pages 158-167.
Crossref
Crossref
A Karalezli, M Borazan, C Kucukerdonmez, A Akman & Y A Akova. (2009) Effect of intracameral triamcinolone acetonide on postoperative intraocular pressure after cataract surgery. Eye 24:4, pages 619-623.
Crossref
Crossref
Mark B. Abelson & Salim Butrus. 2008. Albert & Jakobiec's Principles & Practice of Ophthalmology. Albert & Jakobiec's Principles & Practice of Ophthalmology
249
258
.
S Russo, V Papa, A Di Bella, A Favero, C Radulescu, O Gafencu, B Carstocea & G Milazzo. (2005) Dexamethasone–netilmicin: a new ophthalmic steroid–antibiotic combination. Efficacy and safety after cataract surgery. Eye 21:1, pages 58-64.
Crossref
Crossref
Yasuaki Hata, Hiroshi Enaida, Yukio Sassa, Akifumi Ueno, Muneki Miura, Toshio Hisatomi, Yoshinobu Goto & Tatsuro Ishibashi. (2006) Preclinical investigation of fluorometholone acetate as a potential new adjuvant during vitreous surgery. Graefe's Archive for Clinical and Experimental Ophthalmology 245:7, pages 1019-1025.
Crossref
Crossref
Dorothy S.P. Fan, K.M.Carmen Chan, Christopher B.O. Yu, Joan S.K. Ng & Dennis S.C. Lam. (2003) Author reply. Ophthalmology 110:6, pages 1073.
Crossref
Crossref
Gary D Novack. (2003) Fluorometholone in children. Ophthalmology 110:6, pages 1072-1073.
Crossref
Crossref
Gary D. Novack. (2002) Dear Dr. Walson. Clinical Therapeutics 24:9, pages 1477-1478.
Crossref
Crossref
Andrea Leonardi, Vincenzo Papa, Giovanni Milazzo & Antonio G. Secchi. (2002) Efficacy and Safety of Desonide Phosphate for the Treatment of Allergic Conjunctivitis. Cornea 21:5, pages 476-481.
Crossref
Crossref
Emilio M. Dodds. (2000) Treatment Strategies in Patients With Anterior Uveitis. International Ophthalmology Clinics 40:2, pages 55-68.
Crossref
Crossref
. (1999) Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. American Journal of Ophthalmology 127:5, pages 537-544.
Crossref
Crossref
David G Shulman, Larry L Lothringer, Jay M Rubin, Richard B Briggs, John Howes, Gary D Novack & Kathryn Hart. (1999) A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis11None of the investigators had a proprietary interest in loteprednol etabonate.. Ophthalmology 106:2, pages 362-369.
Crossref
Crossref
Robert Stewart, Barry Horwitz, John Howes, Gary D. Novack & Kathryn Hart. (1998) Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5 for postoperative inflammation. Journal of Cataract and Refractive Surgery 24:11, pages 1480-1489.
Crossref
Crossref
Steven J. Dell, George M. Lowry, James A. Northcutt, John Howes, Gary D. Novack & Kathryn Hart. (1998) A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis. Journal of Allergy and Clinical Immunology 102:2, pages 251-255.
Crossref
Crossref
JOHN HOWES & GARY D. NOVACK. (1998) Failure to Detect Systemic Levels, and Effects of Loteprednol Etabonate and its Metabolite, PJ-91, Following Chronic Ocular Administration. Journal of Ocular Pharmacology and Therapeutics 14:2, pages 153-158.
Crossref
Crossref
STEVEN J. DELL, DAVID G. SHULMAN, GEORGE M. LOWRY & JOHN HOWES. (1997) A Controlled Evaluation of the Efficacy and Safety of Loteprednol Etabonate in the Prophylactic Treatment of Seasonal Allergic Conjunctivitis. American Journal of Ophthalmology 123:6, pages 791-797.
Crossref
Crossref
MITCHELL H. FRIEDLAENDER & JOHN HOWES. (1997) A Double-masked, Placebo-controlled Evaluation of the Efficacy and Safety of Loteprednol Etabonate in the Treatment of Giant Papillary Conjunctivitis. American Journal of Ophthalmology 123:4, pages 455-464.
Crossref
Crossref
Ricardo Notivol, Miguel Martínez, Michael V.W. Bergamini & Pranoprofen Study Group. (1994) Treatment of Chronic Nonbacterial Conjunctivitis With a Cyclo-oxygenase Inhibitor or a Corticosteroid. American Journal of Ophthalmology 117:5, pages 651-656.
Crossref
Crossref
Michael Kass, Janet Cheetham, Efraim Duzman & P. Joshua Burke. (1986) The Ocular Hypertensive Effect of 0.25% Fluorometholone in Corticosteroid Responders. American Journal of Ophthalmology 102:2, pages 159-163.
Crossref
Crossref